1. Signaling Pathways
  2. Immunology/Inflammation
  3. Kallikrein

Kallikrein (激肽释放酶)

KLK; Kallikrein-related peptidase

Kallikrein 是一种丝氨酸蛋白酶,在激肽释放酶-激肽系统中至关重要。血浆 Kallikrein 特异性地在肝细胞中表达,作用于高分子量激肽原释放缓激肽,参与血管紧张度调节、炎症反应以及内源性凝血和纤溶过程。组织 Kallikrein 广泛分布于肺、肾、脑等多种组织,作用于低分子量激肽原生成激肽,参与血压调节、电解质平衡和神经元保护等过程。此外,Kallikrein 还能结合低密度脂蛋白受体,促进其经溶酶体途径降解,并且与酸敏感离子通道相互作用,影响中枢神经系统中的神经元功能。激肽释放酶活性失调与心脏病、肾病、癌症等多种疾病相关[1][2]

Kallikrein is a serine protease that plays a crucial role in the kallikrein-kinin system. Plasma kallikrein, specifically expressed in hepatocytes, acts on high molecular weight kininogen to release bradykinin, which is involved in regulating vascular tone, inflammatory response, and endogenous blood coagulation and fibrinolysis. Tissue kallikrein, widely distributed in various tissues such as the lung, kidney, and brain, acts on low molecular weight kininogen to produce kinin, participating in processes like blood pressure regulation, electrolyte balance, and neuronal protection. Additionally, kallikrein can bind to LDLR, promoting its lysosomal degradation, and interact with ASICs to affect neuronal function in the central nervous system. Dysregulation of kallikrein activity is associated with various diseases including heart disease, kidney disease, and cancer[1][2].

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-167924
    Ono 3307 free base
    Ono 3307 Free base 是一种合成蛋白酶抑制剂,通过预防高淀粉酶血症和胰腺水肿,对急性胰腺炎具有保护作用。Ono 3307 Free base 还能抑制腺泡细胞中溶酶体酶的重新分布,并减轻乳酸脱氢酶的排出。Ono 3307 Free base 能以剂量依赖性方式有效减少溶酶体中蛋白酶 B 的泄漏。Ono 3307 Free base?能够靶向胰蛋白酶?(Ki=48 nM)、凝血酶?(Ki=0.18 μM)、血浆激肽释放酶?(Ki=0.29 μM)、纤溶酶?(Ki=0.31 μM)、胰激肽释放酶?(Ki=3.6 μM)和糜蛋白酶?(Ki=47 μM)。
    Ono 3307 free base
  • HY-122543A
    PPACK II Inhibitor
    PPACK II 是一种不可逆的特异性腺体和血浆激肽释放酶 (kallikreins) 抑制剂。
    PPACK II
  • HY-19101
    ONO-3307 Inhibitor
    ONO-3307 是一种蛋白酶 (protease) 抑制剂,能竞争性地抑制包括胰蛋白酶、凝血酶、血浆激肽释放酶、纤溶酶、胰腺激肽释放酶和胰凝乳酶在内的多种蛋白酶。ONO-3307 可缓解内毒素诱导的大鼠实验性弥漫性血管内凝血 (DIC)。ONO-3307 可用于血栓形成和蛋白酶介导疾病的研究。
    ONO-3307
  • HY-139787A
    Donidalorsen sodium Inhibitor
    Donidalorsen (sodium) 是一种反义寡核苷酸,减少 prekallikrein (PKK) 的产生,PKK在与遗传性血管性水肿(HAE)急性发作相关的炎症介质的激活中起重要作用。
    Donidalorsen sodium
  • HY-P990459
    Anti-KLK5/Kallikrein 5 Antibody Inhibitor
    Anti-KLK5/Kallikrein 5 Antibody 是 CHO 表达的人源抗体,靶向 KLK5/Kallikrein 5。Anti-KLK5/Kallikrein 5 Antibody 带有 huIgG1 型重链和 huκ 型轻链,其预测的分子量 (MW) 为 150 kDa。Anti-KLK5/Kallikrein 5 Antibody 的同型对照可参考 Human IgG1 kappa, Isotype Control (HY-P99001)。
    Anti-KLK5/Kallikrein 5 Antibody
  • HY-150052
    Plasma kallikrein-IN-3 Inhibitor
    Plasma kallikrein-IN-3 是一种血浆激肽释放酶 (plasma kallikrein) 抑制剂 (IC50: 0.15 μM)。Plasma kallikrein-IN-3 可用于遗传性血管性水肿、糖尿病性黄斑水肿和糖尿病性视网膜病变研究。
    Plasma kallikrein-IN-3
  • HY-P5027
    Cbz-Lys-Arg-pNA Substrate
    Cbz-Lys-Arg-pNA 是一种含有对乙酰氨基酚 (pNA) 作为显色基团的肽底物。Cbz-Lys-Arg-pNA 广泛应用于酶促分析,包括凝血酶 (thrombin)、纤溶酶 (plasmin)、Xa 因子 (factor Xa) 和激肽释放酶 (Kallikrein)。
    Cbz-Lys-Arg-pNA
  • HY-143476
    Plasma kallikrein-IN-2 Inhibitor
    Plasma kallikrein-IN-2 (Compound 198) 是一个有效的 plasma kallikrein (PKal) 抑制剂,IC50 值为 0.1 nM。Plasma kallikrein-IN-2 可用于遗传性血管水肿、糖尿病性黄斑水肿、糖尿病视网膜病变的研究。
    Plasma kallikrein-IN-2
  • HY-P0237
    KKI-5

    激肽释放酶抑制剂

    KKI-5 是一种特异性的组织激肽释放酶 (kallikrein) 抑制剂。KKI-5 可降低乳腺癌细胞浸润。
    KKI-5
目录号 产品名 / 同用名 应用 反应物种

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.